Maya Koren-Michowitz

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 10

Top Venues

Leukemia & lymphoma

Vox sanguinis

American journal of hematology

PloS one

This page only lists publications with an associated author ORCID identifier.

Publications

Dorit Blickstein, Marina Izak, Talia Filipovich-Rimon, Osnat Garach-Jehoshua, Naomi Rahimi-Levene, Eilat Shinar, Ramzia Abu Hamad, Adina Bar-Chaim, Maya Koren-Michowitz
Antiphospholipid antibodies in convalescent plasma of donors recovered from mild COVID-19 infection. Vox sanguinis (2023)
Odit Gutwein, Katrin Herzog Tzarfati, Arie Apel, Naomi Rahimi-Levene, Hani Michaeli, Liza Barki-Harrington, Maya Koren-Michowitz
Haematological patients' perception of home transfusions: Effect of the COVID-19 pandemic. Vox sanguinis 117 (10) (2022)
Katrin Herzog Tzarfati, Odit Gutwein, Arie Apel, Naomi Rahimi-Levene, Maya Sadovnik, Lotem Harel, Patricia Benveniste-Levkovitz, Adina Bar Chaim, Maya Koren-Michowitz
BNT162b2 COVID-19 vaccine is significantly less effective in patients with hematologic malignancies. American journal of hematology 96 (10) (2021)
Ilana Levy Yurkovski, Avital Lavi, Eran Zimran, Sigal Grisariu, Shlomzion Aumann, Gilad Itchaki, Tamar Berger, Pia Raanani, Reut Harel, Ariel Aviv, Noa Lavi, Tsila Zukerman, Lev Shvidel, Osnat Jarchowsky, Martin Ellis, Katrin Herzog Tzarfati, Maya Koren-Michowitz, Yehonatan Sherf, Itai Levi, Orit Sofer, Ofer Shpilberg, Nagib Dally, Celia Suriu, Andrei Braester, Sharon Ben Barouch, Merav Leiba, Daniela Goldstein, Nadav Sarid, Shay Yeganeh, Jabour Halloun, Moshe Mittelman, Tamar Tadmor
COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome. Leukemia & lymphoma (2021)
Chezi Ganzel, Ron Ram, Alexander Gural, Ofir Wolach, Sharon Gino-Moor, Vladimir Vainstein, Boaz Nachmias, Arie Apel, Maya Koren-Michowitz, Oren Pasvolsky, Ronit Yerushalmi, Ivetta Danylesko, Yosef Cohen, Galit Peretz, Yakir Moshe, Miri Zektser, Shay Yeganeh, Jacob M Rowe, Yishai Ofran
Venetoclax is safe and efficacious in relapsed/refractory AML. Leukemia & lymphoma 61 (9) (2020)
Hagit Hauschner, Melanie Bokstad Horev, Modi Misgav, Meital Nagar, Uri Seligsohn, Nurit Rosenberg, Maya Koren-Michowitz
Platelets from Calreticulin mutated essential thrombocythemia patients are less reactive than JAK2 V617F mutated platelets. American journal of hematology 95 (4) (2020)
Muhammad Yassin, Nasma Aqaqe, Abed Alkader Yassin, Peter van Galen, Eitan Kugler, Bradley E Bernstein, Maya Koren-Michowitz, Jonathan Canaani, Arnon Nagler, Eric R Lechman, John E Dick, Erno Wienholds, Shai Izraeli, Michael Milyavsky
A novel method for detecting the cellular stemness state in normal and leukemic human hematopoietic cells can predict disease outcome and drug sensitivity. Leukemia 33 (8) (2019)
Yoav Michowitz, Robert Klempfner, Nir Shlomo, Ilan Goldenberg, Maya Koren-Michowitz
Thrombocytopenia and thrombocytosis are associated with different outcome in atrial fibrillation patients on anticoagulant therapy. PloS one 14 (11) (2019)
Naomi Rahimi-Levene, Tomer Ziv-Baran, Victoria Peer, Ahuva Golik, Abraham Kornberg, Ronit Zeidenstein, Maya Koren-Michowitz
Hemoglobin transfusion trigger in an internal medicine department - A "real world" six year experience. PloS one 13 (3) (2018)
Maya Koren-Michowitz, Noa Lavi, Martin H Ellis, Alessandro M Vannucchi, Ruben Mesa, Claire N Harrison
Management of extreme thrombocytosis in myeloproliferative neoplasms: an international physician survey. Annals of hematology 96 (1) (2016)

Maya Koren-Michowitz.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Maya Koren-Michowitz